Global Human Milk Glycans Market

Human Milk Glycans Comprehensive Study by Application (Hospitals, Clinics, Pharmacies), Components (Macro-micro Nutrients, Water, Human Milk), Forms (Liquid, Powder) Players and Region - Global Market Outlook to 2027

Human Milk Glycans Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Human milk glycans are composed of components like lactose and oligosaccharides which is about 6.8 and 1% of the milk respectively. The glycans are enriched with nutrition, with other bioactive components. It is needed for the development of infants' microflora and immune systems. Other sources of glycans include mucins, glycosaminoglycans, monosaccharides, glycoproteins, glycopeptides, and glycolipids.This growth is primarily driven by Growing Number of Pregnant Women .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies in StudyDSM (Netherlands), Jennewein Biotechnologie GmbH (Germany), Biosynth Carbosynth (United States), Lonza Group (Switzerland), DuPont Nutrition & Health (United States), Inbiose NV (Belgium) and zuChem (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Globally, a noticeable market trend is evident Continuous Research and Development in Human Milk Glycans. Major Players, such as DSM (Netherlands), Jennewein Biotechnologie GmbH (Germany), Biosynth Carbosynth (United States), Lonza Group (Switzerland), DuPont Nutrition & Health (United States), Inbiose NV (Belgium) and zuChem (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 02 October 2020, Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces the completion of its acquisition of Erber Group DSM acquired Erber Group’s Biomin and Romer Labs. Erber Group’s specialty animal nutrition and health business Biomin specializes primarily in mycotoxin risk management and gut health performance management, whereas the Romer Labs business focuses on food and feed safety diagnostic solutions. Both expand DSM’s range of higher value-add specialty solutions.
On 3rd April 2020, DSM, a global science-based company in Nutrition, Health, and Sustainable Living, announced the completion of its acquisition of Glyco, the world’s leading supplier of Human Milk Oligosaccharides (HMOs). The acquisition of Glycom was first announced on 21 February 2020. There is significant interest in HMO use as a dietary supplement and potentially in food and beverage and pet food applications, and in fulfilling unmet medical nutrition needs, such as irritable bowel syndrome

Market Drivers
  • Growing Number of Pregnant Women
  • Need for Development of Infants Microflora and Immune System

Market Trend
  • Continuous Research and Development in Human Milk Glycans

Restraints
  • Prevailing Human Disease Might be the Problem in Human Milk Glycans

Opportunities
Increasing Awareness about the Human Milk Oligosaccharide will Boost the Human Milk Glycan Market as it is the Composition of Oligosaccharide
Challenges
Regulatory Guidelines on Human Milk Glycans

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Human Milk Glycans Study Sheds Light on
— The Human Milk Glycans Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Human Milk Glycans industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Human Milk Glycans industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Clinics
  • Pharmacies
By Components
  • Macro-micro Nutrients
  • Water
  • Human Milk

By Forms
  • Liquid
  • Powder

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Pregnant Women
      • 3.2.2. Need for Development of Infants Microflora and Immune System
    • 3.3. Market Challenges
      • 3.3.1. Regulatory Guidelines on Human Milk Glycans
    • 3.4. Market Trends
      • 3.4.1. Continuous Research and Development in Human Milk Glycans
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Human Milk Glycans, by Application, Components, Forms and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Human Milk Glycans (Value)
      • 5.2.1. Global Human Milk Glycans by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Clinics
        • 5.2.1.3. Pharmacies
      • 5.2.2. Global Human Milk Glycans by: Components (Value)
        • 5.2.2.1. Macro-micro Nutrients
        • 5.2.2.2. Water
        • 5.2.2.3. Human Milk
      • 5.2.3. Global Human Milk Glycans by: Forms (Value)
        • 5.2.3.1. Liquid
        • 5.2.3.2. Powder
      • 5.2.4. Global Human Milk Glycans Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Human Milk Glycans (Price)
  • 6. Human Milk Glycans: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DSM (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Jennewein Biotechnologie GmbH (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biosynth Carbosynth (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Lonza Group (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DuPont Nutrition & Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Inbiose NV (Belgium)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ZuChem (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Human Milk Glycans Sale, by Application, Components, Forms and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Human Milk Glycans (Value)
      • 7.2.1. Global Human Milk Glycans by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Clinics
        • 7.2.1.3. Pharmacies
      • 7.2.2. Global Human Milk Glycans by: Components (Value)
        • 7.2.2.1. Macro-micro Nutrients
        • 7.2.2.2. Water
        • 7.2.2.3. Human Milk
      • 7.2.3. Global Human Milk Glycans by: Forms (Value)
        • 7.2.3.1. Liquid
        • 7.2.3.2. Powder
      • 7.2.4. Global Human Milk Glycans Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Human Milk Glycans (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Human Milk Glycans: by Application(USD Million)
  • Table 2. Human Milk Glycans Hospitals , by Region USD Million (2016-2021)
  • Table 3. Human Milk Glycans Clinics , by Region USD Million (2016-2021)
  • Table 4. Human Milk Glycans Pharmacies , by Region USD Million (2016-2021)
  • Table 5. Human Milk Glycans: by Components(USD Million)
  • Table 6. Human Milk Glycans Macro-micro Nutrients , by Region USD Million (2016-2021)
  • Table 7. Human Milk Glycans Water , by Region USD Million (2016-2021)
  • Table 8. Human Milk Glycans Human Milk , by Region USD Million (2016-2021)
  • Table 9. Human Milk Glycans: by Forms(USD Million)
  • Table 10. Human Milk Glycans Liquid , by Region USD Million (2016-2021)
  • Table 11. Human Milk Glycans Powder , by Region USD Million (2016-2021)
  • Table 12. South America Human Milk Glycans, by Country USD Million (2016-2021)
  • Table 13. South America Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 14. South America Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 15. South America Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 16. Brazil Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 17. Brazil Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 18. Brazil Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 19. Argentina Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 20. Argentina Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 21. Argentina Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 22. Rest of South America Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 23. Rest of South America Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 24. Rest of South America Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 25. Asia Pacific Human Milk Glycans, by Country USD Million (2016-2021)
  • Table 26. Asia Pacific Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 27. Asia Pacific Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 28. Asia Pacific Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 29. China Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 30. China Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 31. China Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 32. Japan Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 33. Japan Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 34. Japan Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 35. India Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 36. India Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 37. India Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 38. South Korea Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 39. South Korea Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 40. South Korea Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 41. Taiwan Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 42. Taiwan Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 43. Taiwan Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 44. Australia Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 45. Australia Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 46. Australia Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 50. Europe Human Milk Glycans, by Country USD Million (2016-2021)
  • Table 51. Europe Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 52. Europe Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 53. Europe Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 54. Germany Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 55. Germany Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 56. Germany Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 57. France Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 58. France Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 59. France Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 60. Italy Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 61. Italy Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 62. Italy Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 63. United Kingdom Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 64. United Kingdom Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 65. United Kingdom Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 66. Netherlands Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 67. Netherlands Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 68. Netherlands Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 69. Rest of Europe Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 70. Rest of Europe Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 71. Rest of Europe Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 72. MEA Human Milk Glycans, by Country USD Million (2016-2021)
  • Table 73. MEA Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 74. MEA Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 75. MEA Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 76. Middle East Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 77. Middle East Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 78. Middle East Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 79. Africa Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 80. Africa Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 81. Africa Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 82. North America Human Milk Glycans, by Country USD Million (2016-2021)
  • Table 83. North America Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 84. North America Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 85. North America Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 86. United States Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 87. United States Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 88. United States Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 89. Canada Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 90. Canada Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 91. Canada Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 92. Mexico Human Milk Glycans, by Application USD Million (2016-2021)
  • Table 93. Mexico Human Milk Glycans, by Components USD Million (2016-2021)
  • Table 94. Mexico Human Milk Glycans, by Forms USD Million (2016-2021)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Human Milk Glycans: by Application(USD Million)
  • Table 103. Human Milk Glycans Hospitals , by Region USD Million (2022-2027)
  • Table 104. Human Milk Glycans Clinics , by Region USD Million (2022-2027)
  • Table 105. Human Milk Glycans Pharmacies , by Region USD Million (2022-2027)
  • Table 106. Human Milk Glycans: by Components(USD Million)
  • Table 107. Human Milk Glycans Macro-micro Nutrients , by Region USD Million (2022-2027)
  • Table 108. Human Milk Glycans Water , by Region USD Million (2022-2027)
  • Table 109. Human Milk Glycans Human Milk , by Region USD Million (2022-2027)
  • Table 110. Human Milk Glycans: by Forms(USD Million)
  • Table 111. Human Milk Glycans Liquid , by Region USD Million (2022-2027)
  • Table 112. Human Milk Glycans Powder , by Region USD Million (2022-2027)
  • Table 113. South America Human Milk Glycans, by Country USD Million (2022-2027)
  • Table 114. South America Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 115. South America Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 116. South America Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 117. Brazil Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 118. Brazil Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 119. Brazil Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 120. Argentina Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 121. Argentina Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 122. Argentina Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 123. Rest of South America Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 124. Rest of South America Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 125. Rest of South America Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 126. Asia Pacific Human Milk Glycans, by Country USD Million (2022-2027)
  • Table 127. Asia Pacific Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 128. Asia Pacific Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 129. Asia Pacific Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 130. China Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 131. China Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 132. China Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 133. Japan Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 134. Japan Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 135. Japan Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 136. India Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 137. India Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 138. India Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 139. South Korea Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 140. South Korea Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 141. South Korea Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 142. Taiwan Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 143. Taiwan Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 144. Taiwan Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 145. Australia Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 146. Australia Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 147. Australia Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 148. Rest of Asia-Pacific Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 149. Rest of Asia-Pacific Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 150. Rest of Asia-Pacific Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 151. Europe Human Milk Glycans, by Country USD Million (2022-2027)
  • Table 152. Europe Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 153. Europe Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 154. Europe Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 155. Germany Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 156. Germany Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 157. Germany Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 158. France Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 159. France Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 160. France Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 161. Italy Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 162. Italy Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 163. Italy Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 164. United Kingdom Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 165. United Kingdom Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 166. United Kingdom Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 167. Netherlands Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 168. Netherlands Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 169. Netherlands Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 170. Rest of Europe Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 171. Rest of Europe Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 172. Rest of Europe Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 173. MEA Human Milk Glycans, by Country USD Million (2022-2027)
  • Table 174. MEA Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 175. MEA Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 176. MEA Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 177. Middle East Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 178. Middle East Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 179. Middle East Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 180. Africa Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 181. Africa Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 182. Africa Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 183. North America Human Milk Glycans, by Country USD Million (2022-2027)
  • Table 184. North America Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 185. North America Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 186. North America Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 187. United States Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 188. United States Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 189. United States Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 190. Canada Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 191. Canada Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 192. Canada Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 193. Mexico Human Milk Glycans, by Application USD Million (2022-2027)
  • Table 194. Mexico Human Milk Glycans, by Components USD Million (2022-2027)
  • Table 195. Mexico Human Milk Glycans, by Forms USD Million (2022-2027)
  • Table 196. Research Programs/Design for This Report
  • Table 197. Key Data Information from Secondary Sources
  • Table 198. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Human Milk Glycans: by Application USD Million (2016-2021)
  • Figure 5. Global Human Milk Glycans: by Components USD Million (2016-2021)
  • Figure 6. Global Human Milk Glycans: by Forms USD Million (2016-2021)
  • Figure 7. South America Human Milk Glycans Share (%), by Country
  • Figure 8. Asia Pacific Human Milk Glycans Share (%), by Country
  • Figure 9. Europe Human Milk Glycans Share (%), by Country
  • Figure 10. MEA Human Milk Glycans Share (%), by Country
  • Figure 11. North America Human Milk Glycans Share (%), by Country
  • Figure 12. Global Human Milk Glycans share by Players 2021 (%)
  • Figure 13. Global Human Milk Glycans share by Players (Top 3) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 16. DSM (Netherlands) Revenue: by Geography 2021
  • Figure 17. Jennewein Biotechnologie GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Jennewein Biotechnologie GmbH (Germany) Revenue: by Geography 2021
  • Figure 19. Biosynth Carbosynth (United States) Revenue, Net Income and Gross profit
  • Figure 20. Biosynth Carbosynth (United States) Revenue: by Geography 2021
  • Figure 21. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. Lonza Group (Switzerland) Revenue: by Geography 2021
  • Figure 23. DuPont Nutrition & Health (United States) Revenue, Net Income and Gross profit
  • Figure 24. DuPont Nutrition & Health (United States) Revenue: by Geography 2021
  • Figure 25. Inbiose NV (Belgium) Revenue, Net Income and Gross profit
  • Figure 26. Inbiose NV (Belgium) Revenue: by Geography 2021
  • Figure 27. ZuChem (United States) Revenue, Net Income and Gross profit
  • Figure 28. ZuChem (United States) Revenue: by Geography 2021
  • Figure 29. Global Human Milk Glycans: by Application USD Million (2022-2027)
  • Figure 30. Global Human Milk Glycans: by Components USD Million (2022-2027)
  • Figure 31. Global Human Milk Glycans: by Forms USD Million (2022-2027)
  • Figure 32. South America Human Milk Glycans Share (%), by Country
  • Figure 33. Asia Pacific Human Milk Glycans Share (%), by Country
  • Figure 34. Europe Human Milk Glycans Share (%), by Country
  • Figure 35. MEA Human Milk Glycans Share (%), by Country
  • Figure 36. North America Human Milk Glycans Share (%), by Country
List of companies from research coverage that are profiled in the study
  • DSM (Netherlands)
  • Jennewein Biotechnologie GmbH (Germany)
  • Biosynth Carbosynth (United States)
  • Lonza Group (Switzerland)
  • DuPont Nutrition & Health (United States)
  • Inbiose NV (Belgium)
  • zuChem (United States)
Select User Access Type

Key Highlights of Report


Jun 2022 139 Pages 62 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Human Milk Glycans Market Quantitative research analysis
Global Human Milk Glycans Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Human Milk Glycans Market are DSM (Netherlands), Jennewein Biotechnologie GmbH (Germany), Biosynth Carbosynth (United States), Lonza Group (Switzerland), DuPont Nutrition & Health (United States), Inbiose NV (Belgium) and zuChem (United States) etc.
Hospitals segment in Global market to hold robust market share owing to "Growing Number of Pregnant Women ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Human Milk Glycans market throughout the forecasted period.

Know More About Global Human Milk Glycans Market Report?

Have a Query? Click Here

Other Related Reports

Paraneoplastic Pemphigus Comprehensive Study by Therapy (High Dose Corticosteroids, Steroid Sparing Agents, Others), Medication (Prednisone, Azathioprine, Ciclosporin, Cyclophosphamide, Others), Tumo...
$ 3650
Antibody Validation Comprehensive Study by Type (Standard Antibody Validation, Enhanced Antibody Validation), Antibodies (IgG, IgM, IgA, IgD, IgE), Assays (Western blot (WB), Immunohistochemistry (IH...
$ 3450
RNase Control Comprehensive Study by Type (Positive Control, No Template Control), Application (Research Institutes, Laboratories, Health Institutes, Others), Function (RNA Cloning, CDNA Synthesis, E...
$ 3650
Globular Protein Comprehensive Study by Type (Recombinant Globular Protein, Bovine Globular Protein, Human Globular Protein), Application (Therapeutics, Vaccine, Other), End Use (Hospitals, Clinics) ...
$ 3500
Yeast Twohybrid System Comprehensive Study by Type (Protein-Protein Interaction, Protein-DNA Interaction), Application (Therapeutic, Industrial, Research), Form (Liquid, Tablet), Distribution Channel...
$ 3650
Biopharmaceutical Equipment Comprehensive Study by Type (Filtration Systems, Bioreactors, Extractors, Chromatography, Cell Culture, Bioprocessing Containers, Sterilizers, Others), Application (Biopro...
$ 3450